The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

twoCoprimary provides comprehensive tools for sample
size and power calculation in clinical trials with two co-primary
endpoints. In co-primary endpoint trials, treatment success requires
demonstrating statistically significant effects on all
primary endpoints simultaneously. This package implements
state-of-the-art methodologies that properly account for correlation
between endpoints, leading to more efficient trial designs.
The package supports five combinations of co-primary endpoints:
All methods provide:
The exact methods for binary endpoints use a compiled kernel for the bivariate binomial distribution and evaluate the co-primary power as a matrix product, so a complete sample size search at a total sample size of several hundred takes about a second. The rejection regions of the Z-pooled and Boschloo exact unconditional tests agree with those of the Exact package.
See NEWS for what changed in version 1.1.0.
Install from CRAN:
install.packages("twoCoprimary")Or install the development version from GitHub:
# install.packages("pak")
pak::pak("gosukehommaEX/twoCoprimary")Calculate sample size for a trial with two continuous co-primary endpoints:
library(twoCoprimary)
# Sample size calculation
result <- ss2Continuous(
delta1 = 0.5, # Effect size for endpoint 1
delta2 = 0.5, # Effect size for endpoint 2
sd1 = 1, # Standard deviation for endpoint 1
sd2 = 1, # Standard deviation for endpoint 2
rho = 0.5, # Correlation between endpoints
r = 1, # Balanced allocation
alpha = 0.025, # One-sided significance level
beta = 0.2, # Type II error (80% power)
known_var = TRUE
)
print(result)
# Sample size calculation for two continuous co-primary endpoints
#
# n1 = 79
# n2 = 79
# N = 158
# delta = 0.5, 0.5
# sd = 1, 1
# rho = 0.5
# allocation = 1
# alpha = 0.025
# beta = 0.2
# known_var = TRUEFor small to medium sample sizes, use exact methods:
# Sample size with exact inference
result_exact <- ss2BinaryExact(
p11 = 0.50, p12 = 0.30, # Response rates for group 1
p21 = 0.30, p22 = 0.10, # Response rates for group 2
rho1 = 0.3, rho2 = 0.3, # Within-group correlations
alpha = 0.025, # One-sided significance level
beta = 0.2, # Type II error (80% power)
r = 1, # Allocation ratio
Test = "Fisher" # Exact test method
)
print(result_exact)
# Sample size calculation for two binary co-primary endpoints
#
# n1 = 111
# n2 = 111
# N = 222
# p (group 1) = 0.5, 0.3
# p (group 2) = 0.3, 0.1
# rho = 0.3, 0.3
# allocation = 1
# alpha = 0.025
# beta = 0.2
# Test = FisherFor COPD/asthma trials with exacerbation count and lung function:
# Sample size calculation
result <- ss2MixedCountContinuous(
r1 = 1.0, # Count rate in treatment group
r2 = 1.25, # Count rate in control group
nu = 0.8, # Dispersion parameter
t = 1, # Follow-up time
mu1 = -50, # Mean for treatment (negative = benefit)
mu2 = 0, # Mean for control
sd = 250, # Standard deviation
r = 1, # Balanced allocation
rho1 = 0.5, # Correlation in treatment group
rho2 = 0.5, # Correlation in control group
alpha = 0.025, # One-sided significance level
beta = 0.2 # Type II error (80% power)
)
print(result)
# Sample size calculation for mixed count and continuous co-primary endpoints
#
# n1 = 705
# n2 = 705
# N = 1410
# sd = 250
# rate = 1, 1.25
# nu = 0.8
# t = 1
# mu = -50, 0
# rho = 0.5, 0.5
# allocation = 1
# alpha = 0.025
# beta = 0.2Comprehensive vignettes are available:
Homma, G., & Yoshida, T. (2024). Sample size calculation in clinical trials with two co-primary endpoints including overdispersed count and continuous outcomes. Pharmaceutical Statistics, 23(1), 46-59. https://doi.org/10.1002/pst.2337
Homma, G., & Yoshida, T. (2025). Exact power and sample size in clinical trials with two co-primary binary endpoints. Statistical Methods in Medical Research, 34(11), 2183-2201. https://doi.org/10.1177/09622802251368697
Sozu, T., Sugimoto, T., & Hamasaki, T. (2010). Sample size determination in clinical trials with multiple co-primary binary endpoints. Statistics in Medicine, 29(21), 2169-2179. https://doi.org/10.1002/sim.3972
Sozu, T., Sugimoto, T., & Hamasaki, T. (2011). Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints. Journal of Biopharmaceutical Statistics, 21(4), 650-668. https://doi.org/10.1080/10543406.2011.551329
Sozu, T., Sugimoto, T., & Hamasaki, T. (2012). Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables. Biometrical Journal, 54(5), 716-729. https://doi.org/10.1002/bimj.201100221
citation("twoCoprimary")MIT © Gosuke Homma
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.